Transfer pricing symptoms of chronic industry challenges

Transfer Pricing Perspectives

The pharmaceutical and life sciences industry is facing a convergence of significant trends - from pricing controls driven by soaring public healthcare costs, to patent lifecycles, parallel trade issues and local marketing intangibles. Many of these changes are driving industry players to reconsider their transfer pricing planning, documentation, and controversy strategies.

This article lays out these and other key issues you may be facing, and offers guidance on how to bring your transfer pricing strategies up to date - while managing the expectations of multiple stakeholders.

Explore each of our Transfer Pricing Perspectives articles

Previous issues of Transfer Pricing Perspectives